Stamford, CT -- (SBWIRE) -- 10/22/2013 -- Jet Life Penny Stocks provides investors with the some of the most Awesome Penny Stock alerts on a regular basis. We will send you alerts through our Penny Stock Newsletter and offer you the tools to help you along the way with the goal of keeping you loyal to our service. Here are some trending Stocks in focus: Meritor Inc(NYSE:MTOR), Antares Pharma Inc(NASDAQ:ATRS), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), American Equity Investment Life Holding(NYSE:AEL)
Meritor Inc(NYSE:MTOR) stock is at $7.99, down -1.72 percent from its previous close of $8.13. The stock opened the session at $8.15 and touched its highest price point at $8.28. Meritor stock’s lowest price point for the session stood at $7.98. Stocks graphical chart shows a bearish trend during its last one month’s trading session. It remained positive 0.38% during the previous three months trade. Its total trading volume is 2.35 million shares for the day, in comparison to its average trading volume of 974,430.00 shares. Meritor, Inc. designs, develops, manufactures, sells, markets, distributes, services, and supports integrated systems, modules, and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation, and industrial sectors.
Has MTOR Found The Bottom and Ready To Move Up? Find Out Here
Antares Pharma Inc(NASDAQ:ATRS) stock is at $4.24, down -2.64 percent from its previous close of $4.36. Its today’s volume is 2.29 million shares, in comparison to its average trading volume of 2.44 million shares. The stock opened the session at $4.34 and touched its highest price point at $4.39. Antares Pharma’s lowest price point for the session stood at $4.20 and its 52 week price range stood at $3.35 - $5.15. The company has a total of 127.16 million outstanding shares and its total market capitalization is $539.15 million. Its beta value stands at 0.69 times and earnings per share was $-0.14. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide.
Has ATRS Found The Bottom And Ready To Gain Momentum? Find Out Here
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) opened the session at $4.51 and remained in the $4.37 to $4.59 price range during the session. The stock is -2.44 percent lower at $4.39. Volume closed the day at 2.27 million shares, its average volume being 5.58 million shares. The company has a total of 218.25 million outstanding shares and its total market capitalization is $958.13 million. Its beta value stands at 0.05 times and earnings per share was $-0.08. ARNA was a gainer in the 5 days activity and jumped about0.46%. The one month performance of the stock was negative and it plunged more than -26.03%.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
American Equity Investment Life Holding(NYSE:AEL) traded in the range of $21.36 and $21.46 in its previous trading session. The stock recorded the volume of 2.24million shares, in comparison to its average daily trading volume of 1.06 million shares. Company’s year to date performance remained optimistic with the rise of 80.37%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of 48.37%. The stock opened at $21.46 and its closing price for the day was $21.41, down -0.23 percent from its previous close of $21.46. American Equity Investment Life Holding Company, through its subsidiaries, operates in the insurance business in 50 states and the District of Columbia.
Will AEL Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Jet Life Penny Stocks also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)